InvestorsHub Logo
Followers 69
Posts 6689
Boards Moderated 0
Alias Born 02/10/2010

Re: chsmoke post# 210391

Friday, 01/24/2020 11:17:53 AM

Friday, January 24, 2020 11:17:53 AM

Post# of 334363
KW has been making the decisions at BIEL for 3 months and 18 days

She has revived the Dr. Scholl's Deal.

She has a Deal with a Global Orthopedic Company which will be ready for signing by the end of January, $2+ million in 2020.

She is negotiating with Mundipharma for Distribution in 30 new Countries.

She has gotten ActiPatch into the McGuire VA Hospital in Virginia.

She is in negotiations for a RecoveryRx Partner.

She has moved the Full Body 510k out of the Limbo it sat in for 3 months to the final stage, Interactive, before Clearance.


Some will complain that this progress has not raised the SP. All of the Partnership Deals have NDAs so we as shareholders know about them through the 'Updates' but other investors do not. The FDA Clearance can not be promoted until the official FDA Letter is sent. There will soon be SP moving PRs.

IMO that is significant progress in 3 and a half months.

**************************************************************

Share Structure

It is no secret that BIEL finances the company through dilution. This has brought us to a 23 billion OS because BIEL, unlike other OTC companies, has not had any Reverse Splits in its 19 year history. The company policy is that the share restructure would be addressed when BIEL had income exceeding expenses.

This is a prudent policy as the average company who does a RS finds their SP quickly falling back to the pre split price.

Case in point, our friends at ENDV. They recently enacted a 1 for 1000 RS. They were trading in the .0014 to .0015 range. The split brought their SP up to 1.50, a few weeks post split they are trading at .98 .

****************************************************************

KW Bailing

KW owns a majority of BIEL via billions of shares. No one stands to benefit more when BIEL is successful. Every time BIEL goes up .0001, one hundredth of one cent, KW increases the value of her shares by hundreds of thousands of dollars. Her best play to maximize the value of her stake in BIEL is to make it a profitable company which also benefits all other shareholders.

Just as relevant as being good for her bank account,KW wants to see BIEL succeed to honor her father and the 20 years he spent developing BIEL.